Your browser doesn't support javascript.
loading
Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation.
Ram, Jodi; Flamm, Gabrielle; Balys, Marlene; Sivagnanalingam, Umayal; Rothberg, Paul G; Iqbal, Anwar; Myers, Jason R; Corbett, Anthony; Ashton, John M; Mendler, Jason H.
Afiliación
  • Ram J; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Flamm G; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Balys M; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Sivagnanalingam U; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Rothberg PG; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Iqbal A; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Myers JR; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Corbett A; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Ashton JM; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Mendler JH; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Blood Adv ; 1(8): 500-503, 2017 Mar 14.
Article en En | MEDLINE | ID: mdl-29296967
ABSTRACT
The persistence of a CEBPA mutation at the time of complete remission warrants germ line analysis.Not all patients harboring germ line CEBPA mutations have a family history of AML.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article